|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
2
|
Coburn NG: Lymph nodes and gastric cancer.
J Surg Oncol. 99:199–206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hippo Y, Yashiro M, Ishii M, Taniguchi H,
Tsutsumi S, Hirakawa K, Kodama T and Aburatani H: Differential gene
expression profiles of scirrhous gastric cancer cells with high
metastatic potential to peritoneum or lymph nodes. Cancer Res.
61:889–895. 2001.PubMed/NCBI
|
|
4
|
Doi T, Muro K, Boku N, Yamada Y, Nishina
T, Takiuchi H, Komatsu Y, Hamamoto Y, Ohno N, Fujita Y, et al:
Multicenter phase II study of everolimus in patients with
previously treated metastatic gastric cancer. J Clin Oncol.
28:1904–1910. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Friis-Hansen L, Sundler F, Li Y, Gillespie
PJ, Saunders TL, Greenson JK, Owyang C, Rehfeld JF and Samuelson
LC: Impaired gastric acid secretion in gastrin-deficient mice. Am J
Physiol. 274:G561–G568. 1998.PubMed/NCBI
|
|
6
|
Rehfeld JF, Lindberg I and Friis-Hansen L:
Progastrin processing differs in 7B2 and PC2 knockout animals: A
role for 7B2 independent of action on PC2. FEBS Lett. 510:89–93.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rehfeld JF, Hansen CP and Johnsen AH:
Post-poly(Glu) cleavage and degradation modified by O-sulfated
tyrosine: A novel post-translational processing mechanism. EMBO J.
14:389–396. 1995.PubMed/NCBI
|
|
8
|
Gutkind JS: The pathways connecting G
protein-coupled receptors to the nucleus through divergent
mitogen-activated protein kinase cascades. J Biol Chem.
273:1839–1842. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang TC, Dangler CA, Chen D, Goldenring
JR, Koh T, Raychowdhury R, Coffey RJ, Ito S, Varro A, Dockray GJ,
et al: Synergistic interaction between hypergastrinemia and
Helicobacter infection in a mouse model of gastric cancer.
Gastroenterology. 118:36–47. 2000. View Article : Google Scholar
|
|
10
|
Rozengurt E and Walsh JH: Gastrin, CCK,
signaling, and cancer. Annu Rev Physiol. 63:49–76. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kulaksiz H, Arnold R, Göke B, Maronde E,
Meyer M, Fahrenholz F, Forssmann WG and Eissele R: Expression and
cell-specific localization of the cholecystokinin B/gastrin
receptor in the human stomach. Cell Tissue Res. 299:289–298. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Watson SA, Morris TM, McWilliams DF,
Harris J, Evans S, Smith A and Clarke PA: Potential role of
endocrine gastrin in the colonic adenoma carcinoma sequence. Br J
Cancer. 87:567–573. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Park WS, Oh RR, Park JY, Lee SH, Shin MS,
Kim YS, Kim SY, Lee HK, Kim PJ, Oh ST, et al: Frequent somatic
mutations of the β-catenin gene in intestinal-type gastric cancer.
Cancer Res. 59:4257–4260. 1999.PubMed/NCBI
|
|
14
|
Kermorgant S and Lehy T: Glycine-extended
gastrin promotes the invasiveness of human colon cancer cells.
Biochem Biophys Res Commun. 285:136–141. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Clements WM, Wang J, Sarnaik A, Kim OJ,
MacDonald J, Fenoglio-Preiser C, Groden J and Lowy AM: β-Catenin
mutation is a frequent cause of Wnt pathway activation in gastric
cancer. Cancer Res. 62:3503–3506. 2002.PubMed/NCBI
|
|
16
|
Gilles C, Polette M, Mestdagt M,
Nawrocki-Raby B, Ruggeri P, Birembaut P and Foidart JM:
Transactivation of vimentin by β-catenin in human breast cancer
cells. Cancer Res. 63:2658–2664. 2003.PubMed/NCBI
|
|
17
|
Kikuchi A: Modulation of Wnt signaling by
Axin and Axil. Cytokine Growth Factor Rev. 10:255–265. 1999.
View Article : Google Scholar
|
|
18
|
Crew KD and Neugut AI: Epidemiology of
gastric cancer. World J Gastroenterol. 12:354–362. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang ZG, Gao L, Guo XB and Shi YL: Roles
of long non-coding RNAs in gastric cancer metastasis. World J
Gastroenterol. 21:5220–5230. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Basu A, Sondarva G, Santha S, Rana A and
Rana B: Elucidation of signaling pathways that mediate
gastrin-induced JNK activation and pGSK3β/Snail induction in
gastric cancer cells. Cancer Res. 75(Suppl 15): 19672015.
View Article : Google Scholar
|
|
21
|
Yakut M, Örmeci N, Erdal H, Keskin O,
Karayel Z, Tutkak H and Soykan I: The association between
precancerous gastric lesions and serum pepsinogens, serum gastrin,
vascular endothelial growth factor, serum interleukin-1 Beta, serum
toll-like receptor-4 levels and Helicobacter pylori Cag A status.
Clin Res Hepatol Gastroenterol. 37:302–311. 2013. View Article : Google Scholar
|
|
22
|
Han YM, Park JM, Park SH, Hahm KB, Hong SP
and Kim EH: Gastrin promotes intestinal polyposis through
cholecystokinin-B receptor-mediated proliferative signaling and
fostering tumor microenvironment. J Physiol Pharmacol. 64:429–437.
2013.PubMed/NCBI
|
|
23
|
Huang BP, Lin CH, Chen YC and Kao SH:
Expression of cholecystokinin receptors in colon cancer and the
clinical correlation in Taiwan. Tumour Biol. 37:4579–4584. 2016.
View Article : Google Scholar
|
|
24
|
Marshall KM, Laval M, Estacio O, Hudson
DF, Kalitsis P, Shulkes A, Baldwin GS and Patel O: Activation by
zinc of the human gastrin gene promoter in colon cancer cells in
vitro and in vivo. Metallomics. 7:1390–1398. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pradeep A, Sharma C, Sathyanarayana P,
Albanese C, Fleming JV, Wang TC, Wolfe MM, Baker KM, Pestell RG and
Rana B: Gastrin-mediated activation of cyclin D1 transcription
involves β-catenin and CREB pathways in gastric cancer cells.
Oncogene. 23:3689–3699. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jie D, Zhongmin Z, Guoqing L, Sheng L, Yi
Z, Jing W and Liang Z: Positive expression of LSD1 and negative
expression of E-cadherin correlate with metastasis and poor
prognosis of colon cancer. Dig Dis Sci. 58:1581–1589. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pang MF and Nelson CM: Intercellular
communication, the tumor microenvironment, and tumor progression.
Intercellular Communication in Cancer. Springer; pp. 343–362. 2015,
View Article : Google Scholar
|
|
28
|
Xu Y, Zhao F, Wang Z, Song Y, Luo Y, Zhang
X, Jiang L, Sun Z, Miao Z and Xu H: MicroRNA-335 acts as a
metastasis suppressor in gastric cancer by targeting Bcl-w and
specificity protein 1. Oncogene. 31:1398–1407. 2012. View Article : Google Scholar :
|
|
29
|
Wang S, Tie J, Wang R, Hu F, Gao L, Wang
W, Wang L, Li Z, Hu S, Tang S, et al: SOX2, a predictor of survival
in gastric cancer, inhibits cell proliferation and metastasis by
regulating PTEN. Cancer Lett. 358:210–219. 2015. View Article : Google Scholar
|
|
30
|
Guo T, Yu Y, Yip GWC, Baeg GH, Thike AA,
Lim TK, Tan PH, Matsumoto K and Bay BH: Y-box binding protein 1 is
correlated with lymph node metastasis in intestinal-type gastric
cancer. Histopathology. 66:491–499. 2015. View Article : Google Scholar
|
|
31
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li Z, Zhang D, Zhang H, Miao Z, Tang Y,
Sun G and Dai D: Prediction of peritoneal recurrence by the mRNA
level of CEA and MMP-7 in peritoneal lavage of gastric cancer
patients. Tumour Biol. 35:3463–3470. 2014. View Article : Google Scholar
|
|
33
|
Shimjura T, Dagher A, Ebi M, Yamada T,
Yamada T, Joh T and Moses MA: Potential of urinary MMP-9/NGAL
complex as a novel biomarker for the early detection of gastric
cancer. Cancer Res. 74(Suppl 19): S892. 2014. View Article : Google Scholar
|
|
34
|
Tsai CY, Wang CS, Tsai MM, Chi HC, Cheng
WL, Tseng YH, Chen CY, Lin CD, Wu JI, Wang LH, et al:
Interleukin-32 increases human gastric cancer cell invasion
associated with tumor progression and metastasis. Clin Cancer Res.
20:2276–2288. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Koh SA, Kim MK, Lee KH, Kim SW and Kim
J-R: RhoGDI2 is associated with HGF-mediated tumor invasion through
VEGF in stomach cancer. Clin Exp Metastasis. 31:805–815. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bienz M and Clevers H: Linking colorectal
cancer to Wnt signaling. Cell. 103:311–320. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Doucas H, Garcea G, Neal CP, Manson MM and
Berry DP: Changes in the Wnt signalling pathway in gastrointestinal
cancers and their prognostic significance. Eur J Cancer.
41:365–379. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Song DH, Kaufman JC, Borodyansky L,
Albanese C, Pestell RG and Wolfe MM: Gastrin stabilises β-catenin
protein in mouse colorectal cancer cells. Br J Cancer.
92:1581–1587. 2005. View Article : Google Scholar : PubMed/NCBI
|
